Rutgers University

Health
United States FDA authorize saliva-based Covid-19 test funded by NBA and NBPA
United States FDA authorize saliva-based Covid-19 test funded by NBA and NBPA
Credit: unsplash.com / NeONBRAND

A saliva-based Covid-19 test developed by the Yale University and funded by the National Basketball Association and the National Basketball Players Association has gotten emergency authorization by the United States Food and Drug Administration.

The new salvia test from Yale University only costs around $4, compared to $60 in the best cased for the competing salvia test that has been developed at Rutgers University lap. Both tests have been granted the same permission by the Food and Drug Administration.